Sporadic Obliterative Bronchiolitis: Case Series and Systematic Review of the Literature Sean J. Callahan, MD, Andrew Vranic, MD, Lucia Flors, MD, Michael.

Slides:

Advertisements

Similar presentations

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pulmonary function in primary pulmonary hypertension.

Advertisements

My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:

Marc H. Bivins, MD, Mark J. Callahan, MD Mayo Clinic Proceedings

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Pulmonary response in sarcoidosis

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Pleomorphic Adenoma in the Parotid Gland

David B. Price, MBBChir, MA, FRCGP, Barbara P

Quantification of emphysema with preoperative computed tomography has stronger association with pulmonary complications than pulmonary function test results.

Evaluation of Proteinuria

William L. Lanier, MD Mayo Clinic Proceedings

Perihilar Cholangiocarcinoma

Shireen Mirza, MBBS, Roberto Benzo, MD Mayo Clinic Proceedings

The Shrinking Lungs Syndrome in Systemic Lupus Erythematosus

Brent A. Bauer, MD, Peter L. Elkin, MD, Dana Erickson, MD, George G

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation Don Hayes, MD, MS, Stephen Kirkby,

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Pulmonary Infiltrates and Eosinophilia Associated With Sulfasalazine

Palliative Care and Hospice Programs

Topical Analgesics in the Management of Acute and Chronic Pain

Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation Nicholas J. Gross, MD,

Acupuncture Mayo Clinic Proceedings

The Vascular-Renal Connection in Patients Hospitalized With Hypertensive Crisis: A Population-Based Study Siu-Hin Wan, MD, Joshua P. Slusser, BS, David.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Impact of Lung Function Changes After Induction Radiochemotherapy on Resected T4 Non-Small Cell Lung Cancer Outcome Jean Perentes, MD, PhD, Sabina Bopp,

Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and Resection Charlotte Billiet, MD, Stéphanie.

Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months Arturo Navarro-Martin, MD, Samantha Aso, MD, Jon Cacicedo,

Using Surgeon-Specific Outcome Reports and Positive Deviance for Continuous Quality Improvement Jelena Ivanovic, MS, PhD, Caitlin Anstee, BA, Tim Ramsay,

Mark F. Berry, MD, Nestor R. Villamizar-Ortiz, MD, Betty C

Regional Emphysema Score Predicting Overall Survival, Quality of Life, and Pulmonary Function Recovery in Early-Stage Lung Cancer Patients Jie Dai, PhD,

Dying in the Intensive Care Unit: A Candle Vigil Using Illustrations

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Marc H. Bivins, MD, Mark J. Callahan, MD Mayo Clinic Proceedings

Patient-Initiated Second Opinions: Systematic Review of Characteristics and Impact on Diagnosis, Treatment, and Satisfaction Velma L. Payne, PhD, Hardeep.

Tara R. Semenkovich, MD, MPHS, Christine Frederiksen, MS, Jessica L

Effects of Extended Pleurectomy and Decortication on Quality of Life and Pulmonary Function in Patients With Malignant Pleural Mesothelioma David Burkholder,

Current Practice in Pulmonary Function Testing

Supreme laryngeal mask airway for laparoscopic cholecystectomy in patient with severe pulmonary fibrosis M. Carron, A. Marchet, C. Ori British Journal.

The Red Scalp Sign Mayo Clinic Proceedings

Joanna Zurko, MD, Amitkumar Mehta, MD

Prospective Study on Functional Results After Lung-Sparing Radical Pleurectomy in the Management of Malignant Pleural Mesothelioma Servet Bölükbas, MD,

Clinical outcomes and changes in lung function after segmentectomy versus lobectomy for lung cancer cases Bo Deng, MD, PhD, Stephen D. Cassivi, MD, Mariza.

Best Practices for Patients With Chronic Migraine

Preoperative pulmonary function tests predict mortality after surgical or transcatheter aortic valve replacement Matthew C. Henn, MD, Alan Zajarias,

Pleomorphic Adenoma in the Parotid Gland

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

The Association of Chronic Lung Disease With Early Mortality and Respiratory Adverse Events After Aortic Valve Replacement Juan A. Crestanello, MD, Robert.

Perihilar Cholangiocarcinoma

Institutional Review Boards: What Clinician Researchers Need to Know

Office-Based Spirometry: A New Model of Care in Preoperative Assessment for Low- Risk Lung Resections Jessica L. Hudson, MD, MPHS, Jennifer M. Bell, BSN,

Pulmonary Hypertension in Patients With Interstitial Lung Diseases

Simon M. Glynn, MD, Sean J. Pittock, MD, Steven A. Vernino, MD, PhD

Leadership Models in Health Care—A Case for Servant Leadership

Michael T. Durheim, MD, Sunghee Kim, PhD, Brian C

Ribavirin in Desquamative Interstitial Pneumonia

Postoperative Trouble

Pulmonary Tumor Embolism of Unknown Origin

Cumulative count of the different primary pulmonary function test (PFT) outcomes in longitudinal studies of systemic sclerosis-associated interstitial.

Shawn Nishi, MD, Jie Zhou, PhD, Yong-Fang Kuo, PhD, James S

Jamie Newman, MD, MHA, Renee E. Ziemer, BA

Medical Treatment of Overactive Bladder: In Response

A) Cumulative count and b) percent cumulative use of the different pulmonary function test (PFT) measures as longitudinal outcomes for systemic sclerosis-associated.

Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance) Michael S. Kent,

Predicted Versus Observed FEV1 and Dlco After Major Lung Resection: A Prospective Evaluation at Different Postoperative Periods Alessandro Brunelli,

Preoperative Smoking Cessation: The Role of the Primary Care Provider

How Good Intentions Contributed to Bad Outcomes: The Opioid Crisis

37-Year-Old Man With Painful Foot

Forest plot of the a) sensitivity and b) specificity of different pulmonary function test screening algorithms for the presence of systemic sclerosis-associated.

Progression in the patient’s pulmonary function tests from 2010 to a) Forced vital capacity (FVC); b) total lung capacity (TLC); c) diffusing capacity.

Is pulmonary function damaged by neoadjuvant lung cancer therapy

Presentation transcript:

Sporadic Obliterative Bronchiolitis: Case Series and Systematic Review of the Literature Sean J. Callahan, MD, Andrew Vranic, MD, Lucia Flors, MD, Michael Hanley, MD, Mark H. Stoler, MD, Borna Mehrad, MD Mayo Clinic Proceedings: Innovations, Quality & Outcomes Volume 3, Issue 1, Pages 86-93 (March 2019) DOI: 10.1016/j.mayocpiqo.2018.10.003 Copyright © 2018 Terms and Conditions

Figure A, Change in physiologic parameters over time in longitudinal follow-up of patients with sporadic obliterative bronchiolitis in the current series. Lighter lines represent data from individual patients; the darker line and dashed lines represent regression line and 95% CI, respectively. B, All-cause mortality of 19 patients with sporadic obliterative bronchiolitis in the current series. Tick mark and dashed lines represent censored patients and 95% CI, respectively. DLCO = diffusing capacity of the lung for carbon monoxide; FEV1 = forced vital capacity in 1 second; FVC = forced vital capacity; PFT = pulmonary function test. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2019 3, 86-93DOI: (10.1016/j.mayocpiqo.2018.10.003) Copyright © 2018 Terms and Conditions